- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01417572
Adjunctive Local Application of Lidocaine During Scleral Buckling Under General Anesthesia
August 15, 2011 updated by: Isfahan University of Medical Sciences
The purpose of this study is to evaluate the effect of topical lidocaine in scleral buckling surgery.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Isfahan, Iran, Islamic Republic of, 7864329800
- Recruiting
- Isfahan University of Medical Sciences
-
Contact:
- amin masjedi, MD
- Phone Number: +983112211915
- Email: Masjedi1827@gmail.com
-
Principal Investigator:
- Amin Masjedi, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 60 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Retinal detachment
- Retinal tear less than 3 hour clock
Exclusion Criteria:
- Vitreous hemorrhage
- Proliferative vitreoretinopathy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: lidocaine
|
to evaluate the effect of lidocaine on oculocardiac reflex during the surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
intraoperative heart rate measurement
Time Frame: 6 month
|
6 month
|
|
decrease in pain and nausea,vomiting after surgery
Time Frame: 6 month
|
6 month
|
|
decrease in ocr after application of topical lidocaine
Time Frame: 6 month
|
6 month
|
|
postoperative nausea and vommitting
Time Frame: 6 month
|
6 month
|
|
postoperative pain
Time Frame: 6 month
|
6 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2010
Primary Completion (ACTUAL)
August 1, 2010
Study Completion (ANTICIPATED)
September 1, 2011
Study Registration Dates
First Submitted
August 9, 2011
First Submitted That Met QC Criteria
August 15, 2011
First Posted (ESTIMATE)
August 16, 2011
Study Record Updates
Last Update Posted (ESTIMATE)
August 16, 2011
Last Update Submitted That Met QC Criteria
August 15, 2011
Last Verified
January 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Eye Diseases
- Retinal Diseases
- Retinal Detachment
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Lidocaine
Other Study ID Numbers
- 199
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.